Nike co-founder Phil Knight to donate $2 billion to OHSU’s Knight Cancer Institute

Nike co-founder Phil Knight to donate  billion to OHSU’s Knight Cancer Institute


Phil Knight

Matthew Staver | Bloomberg | Getty Images

Nike co-founder Phil Knight is donating $2 billion to the Oregon Health and Science University’s Knight Cancer Institute, the single largest donation ever to a U.S. university, college or health institution, according to the Knight Foundation.

The foundation said on Thursday the gift that will be used to shift the scientific approach to cancer treatment, research and patient care outcomes.

As part of the gift, the Knights will partner with cancer research pioneer Dr. Brian Druker.

A decade ago, Druker and OHSU took on a challenge to raise $500 million for cancer research, and the Knights signed on to match the raise dollar-for-dollar.

“We are grateful for the opportunity to invest in the next stage of the Druker-led revolutionary vision of cancer research, diagnosis, treatment, care, and some day, eradication,” Phil and Penny Knight said in a statement. “We couldn’t be more excited about the transformational potential of this work for humanity.”

Phil and Penny Knight with Dr. Brian Druker of the OHSU Knight Cancer Institute.

Courtesy of OHSU Knight Cancer Institute.

Knight’s fortune stems from his success with the swoosh, the company he founded in 1964.

Originally called Blue Ribbon Sports, the business began humbly, with Knight selling sneakers out of the trunk of his car, as he recounted in his 2016 memoir, “Shoe Dog.”

Get the CNBC Sport newsletter directly to your inbox

The CNBC Sport newsletter with Alex Sherman brings you the biggest news and exclusive interviews from the worlds of sports business and media, delivered weekly to your inbox.

Subscribe here to get access today.

Nike went public in December 1980 and quickly became the most dominant sneaker brand, partnered with some of the top athletes across sport.

During Knight’s tenure at the public company, from its IPO to his June 2016 retirement, Nike shares soared almost 30,500%.

Although Nike stock has had a painful few years, down more than 50% from its peak in late 2021, it remains the most valuable public company in athletic footwear, valued at more than $110 billion.

The Knights are regularly found on lists of top philanthropists. In May, Time Magazine estimated their lifetime giving at $3.6 billion, including $370 million gifted in 2024 alone.

According to the Knight Foundation’s latest tax documents the foundation held more than $5 billion in assets at the end of 2023.

“I wanted to build something that was my own, something I could point to and say: I made that. It was the only way I saw to make life meaningful,” Knight said in his 2016 memoir.

Correction: The headline on this story has been updated to correct that Phil Knight is donating to Oregon Health and Science University’s Knight Cancer Institute. A previous version misstated the institution.



Source

Inside politics of broken, unaffordable U.S. health care, Cityblock CEO Toyin Ajayi sees opportunity
Health

Inside politics of broken, unaffordable U.S. health care, Cityblock CEO Toyin Ajayi sees opportunity

For the first time in decades, people are having real conversations about health care, “from the ground up,” says Dr. Toyin Ajayi. That has her feeling optimistic. “We’re in a moment where health and health care — and what it means to be healthy — is the subject of a national discussion,” the co-founder and […]

Read More
Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform Methodiq
Health

Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform Methodiq

Methodiq brand advertisement. Courtesy: Methodiq Il Makiage parent company Oddity is branching out into medical-grade skin care with its new brand Methodiq, as the online retailer looks to compete with Hims and help to address what it called a “broken medical care system.”  Methodiq, which has been in the works for four years and launched […]

Read More
Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to 9 a month
Health

Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month

Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024. Hollie Adams | Reuters Novo Nordisk on Monday said it has cut the direct-to-consumer prices of its blockbuster weight loss drug Wegovy and diabetes counterpart Ozempic, adding to efforts by the company and the Trump administration to […]

Read More